APA (7th ed.) Citation

Glasmacher, A., Goldschmidt, H., Mezger, J., Haferlach, T., Schmidt-Wolf, I. G. H., & Gieseler, F. (2004). Oral idarubicin, dexamethasone and vincristine in the treatment of multiple myeloma: Final analysis of a phase II trial. Haematologica, 89(3), . https://doi.org/10.3324/%x

Chicago Style (17th ed.) Citation

Glasmacher, Axel, Hartmut Goldschmidt, Jörg Mezger, Torsten Haferlach, Ingo G. H. Schmidt-Wolf, and Frank Gieseler. "Oral Idarubicin, Dexamethasone and Vincristine in the Treatment of Multiple Myeloma: Final Analysis of a Phase II Trial." Haematologica 89, no. 3 (2004). https://doi.org/10.3324/%x.

MLA (9th ed.) Citation

Glasmacher, Axel, et al. "Oral Idarubicin, Dexamethasone and Vincristine in the Treatment of Multiple Myeloma: Final Analysis of a Phase II Trial." Haematologica, vol. 89, no. 3, 2004, https://doi.org/10.3324/%x.